David Michael Johnson Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity
David Michael Johnson is Director of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 192,818 shares of ZNTL, which is worth approximately $603,520. The most recent transaction as insider was on Jun 21, 2024, when has been sold 48,429 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
193K
0%
3M change
33.54%
12M change
Total Value Held
$603,520
David Michael Johnson Transaction History
Also insider at
DMJ
David Michael Johnson
Director
New York, NY